2009
DOI: 10.1002/ardp.200900048
|View full text |Cite
|
Sign up to set email alerts
|

Relationship Between Anticancer Activity and Stereochemistry of Saldach Ligands and their Iron(III) Complexes

Abstract: (R,R)-, (S,S)- and (R,S)-N,N'-bis(salicylidene)-1,2-diaminocyclohexane (saldach) and their iron(III) complexes were screened for anticancer activity against MCF-7 and MDA-MB 231 breast cancer as well as HT-29 colon carcinoma cells. Antiproliferative effects depended on the presence of the central atom iron but were independent on the configuration at the saldach ligand. While the free ligands were inactive, the iron(III) derivatives displayed anticancer activity within a concentration range of 1 to 5 microM ir… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 22 publications
0
20
0
Order By: Relevance
“…All target compounds were first evaluated for growth inhibitory activity against MCF‐7 and MDA‐MB 231 breast cancer and HT‐29 colon cancer cell lines according to a previous method 19. In addition to the target compounds 6a–f , 7a–f , gefitinib, dasatinib as well as the established cytostatic agent 5‐fluorouracil (5‐FU) were used as additional references.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…All target compounds were first evaluated for growth inhibitory activity against MCF‐7 and MDA‐MB 231 breast cancer and HT‐29 colon cancer cell lines according to a previous method 19. In addition to the target compounds 6a–f , 7a–f , gefitinib, dasatinib as well as the established cytostatic agent 5‐fluorouracil (5‐FU) were used as additional references.…”
Section: Resultsmentioning
confidence: 99%
“…The experiments were performed according to established procedures with some modifications 19. In 96‐well plates 100 µL of a cell suspension in culture medium (7500 cells/mL (MCF‐7 and MDA‐MB 231) or 3000 cells/mL (HT‐29)) were plated into each well and were incubated for three days under culture conditions.…”
Section: Methodsmentioning
confidence: 99%
“…7,9 Interestingly, applications of salen compounds are not confined to catalysis, since some were found to have particular cytotoxic properties. 10 Considering that the phosphonic moiety provides distinct complexing 11 and pharmacological 12,13 properties to a molecule, and that 5-membered heteroaromatic rings are of importance for pharmacological activity of compounds, our studies have been focused on the aza-Pudovik reaction of variously modified salen-like imines. Thus, the most interesting aspect of this work concerns the stereochemistry of the reaction.…”
Section: Introductionmentioning
confidence: 99%
“…Its use in pharmaceutical research increased with the observation made by Kidani et al in the early 1980s, namely that platinum complexes bearing DACH exhibit excellent antitumor activity which ultimately led to the development of oxaliplatin and its benefits for therapy 13–15. However, detailed information on the antileukemic activity of non‐platinum 1,2‐diaminocyclohexane and 1,2‐diarylethylenediamine complexes is still limited 16–18.…”
Section: Introductionmentioning
confidence: 99%
“…In the next step, the 1,2‐diarylethane moiety was replaced with cyclohexane or benzene in order to modulate the oxygen attachment, thus resulting in [ N , N ′‐bis(salicylidene)‐1,2‐phenylenediamine]iron(II/III) and ‐manganese(II/III) as well as [ rac ‐trans‐ N , N ′‐bis(salicylidene)‐1,2‐cyclohexanediamine]iron(II/II) complexes that induce cytotoxic effects on mammary and colon carcinoma cells (see C in Scheme ) 18, 23.…”
Section: Introductionmentioning
confidence: 99%